PredictImmune raises £4.3 million for trial of assay

The Wellcome Trust has awarded £4.3 million to PredictImmune of Cambridge UK to finance a clinical trial of the company’s prognostic biomarker test for Crohn’s disease. The assay was developed by researchers at the University of Cambridge.